A New Link Between Alzheimer’s Risk Gene and Neuroinflammation
A study published in *Immunity* reveals a direct molecular mechanism for how the Alzheimer’s disease (AD) risk gene INPP5D influences brain health. Researchers identified INPP5D as a key repressor of RIPK1 kinase, a protein known to drive neuroinflammatory signaling. In aging microglia, deficiency of INPP5D leads to unchecked RIPK1 activity, which in turn activates diverse innate immune pathways. This cascade promotes pathologies linked to AD, including TDP-43 aggregation and neuronal loss, and may also connect to mechanisms in other neurodegenerative conditions like amyotrophic lateral sclerosis (ALS).
Why it might matter to you: This work moves a known genetic risk factor from association to mechanism, pinpointing RIPK1 as a central node in disease-relevant immune signaling. For researchers focused on cell signaling pathways in disease, it highlights a potential therapeutic axis where modulating RIPK1 activity could counteract harmful neuroinflammation. Understanding this specific link between genetic risk and cellular dysfunction refines the search for targeted interventions in Alzheimer’s and related disorders.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
